Sales value of leading ethical drugs Japan 2022
In 2022, Opdivo was the leading medicament in Japan, reaching a sales value of approximately 152.4 billion Japanese yen. Opdivo is an immunotherapy agent and is mainly used to treat malignant melanoma in Japan.